Invitrogen™ Human Azurocidin/CAP37/HBP ELISA Kit

Ref.: BL-RE-090938Manufacturer ref.: EH39RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human Azurocidin/CAP37/HBP quantitates human Azurocidin/CAP37/HBP in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Azurocidin/CAP37/HBP.

Accession number
AZAMP; AZU; AZU1; azurocidine; azurocidine 1; CAP37; cationic antimicrobial protein 37; cationic antimicrobial protein CAP37; HBP; l-heparin binding protein; hHBP; HUMAZUR; NAZC ; neutrophil azurocidine
Dose range
0.42 to 100 ng/ml
Sensitivity of the dosage
0.42 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human Azurocidin/CAP37/HBP quantitates human Azurocidin/CAP37/HBP in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Azurocidin/CAP37/HBP.

Human Azurocidin/CAP37/HBP quantitates human Azurocidin/CAP37/HBP in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Azurocidin/CAP37/HBP.

L-azurocidine, also known as the heparin binding protein (HBP), is an inactive counterpart of serine proteinases in granulocytes. Initially, it was thought that she had only one activity against Gram-negative bacteria. Later, it was found to be active against Gram-positive bacteria and C. albicans. L的azurocidine is considered to be a member of the family of antimicrobial proteins derived from polymorphonuclear leukocytes such as defensins, LL-37 and lysozyme. L-azurocidine has been recognized as playing a role in the activation and modulation of the immune reaction and can act to trigger the immune system alarm. The cationic domain on one side of the protein is essential to its antimicrobial activity. It is stored in azurophilic grains as well as secretory grains and is therefore partially released at the beginning of extravasation. L的azurocidine is involved in chemotaxia and monocyte activation, cytokine release, and phagocytosis, which allows for more effective bacterial clearance. The primary target environment of l-azurocidine is the bloodstream cells, i.e. the endothelial wall and the extravascular environment. The interaction with leukocytes is mediated by beta 2-integrins. High plasma levels of d-azurocidine may help identify patients at risk of developing sepsis.

Sensitivity

Sensitivity of the dosage: 0.42 ng/ml.

Measurement range

Dose range: 0.42 to 100 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: Azurocidine.

Samples

Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17155179
Specifications
Accession numberAZAMP; AZU; AZU1; azurocidine; azurocidine 1; CAP37; cationic antimicrobial protein 37; cationic antimicrobial protein CAP37; HBP; l-heparin binding protein; hHBP; HUMAZUR; NAZC ; neutrophil azurocidine
Dose range0.42 to 100 ng/ml
Sensitivity of the dosage0.42 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P20160
Gene symbol(s)AZU1
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetAzurocidine
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; plasma, 50 µl; supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH39RBX5
Country of originUnited States
HS customs code3002 15 00 00
A question or a specific configuration?
Contact us for a quote.